Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
Status:
Completed
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the two suggested therapies for prevention of
recurrent preterm birth (PTB) in women with a prior spontaneous preterm birth, vaginal and
intramuscular progesterone to determine whether vaginal progesterone is superior to
intramuscular progesterone in the prevention of recurrent preterm birth.
Phase:
Phase 4
Details
Lead Sponsor:
Thomas Jefferson University
Collaborators:
Baystate Medical Center George Washington University Ohio State University Vriginia Commonwealth University